Answers are grounded in this paper and cite their sources.
Case report reveals benefits of cfDNA screening for detecting genetic abnormalities in fetuses, emphasizing its role in guiding decisions.
This case demonstrates the value of cell‐free DNA (cfDNA) screening for detecting subchromosomal microdeletions in fetuses with non‐specific prenatal screening abnormalities and no overt structural malformations on ultrasound; CMA and karyotyping confirmation and integrated genetic counseling are essential for diagnosing 5q14.3q15 deletion‐related BBSOAS and guiding parental decision‐making.
No takes yet. Share an insight, caveat, or question.
Hao et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: